GENFI · FORENSICS

BASIS+%$3.10 close 2026-10-05

LIVE STRUCTURE

07:24:53 ET 8-K (two NVIDIA B300 systems, $1,177,431: one leased to Goodwill Labs at ~$117.7K/yr, one financed by an interest-free $589K loan; first print 31 s later) drove pre-market to +102.6% by 09:30 (indication only; window complete) on 41.24M sh vs 665,811 O/S; third GPU release in 46 days; cash $141,831 at 6/30 and the deal uses all estimated free cash; Streeterville prepaid (~$1.5–1.9M) can demand cash or stock at 80% of the low VWAP from ~Oct 12; shelf $0, offering covenant to Oct 27; ~635K registered reset-warrant shares (~$3.15, ESTIMATE) sellable on cash exercise

NEXT WATCH

Streeterville purchase notice or cash demand (~Oct 12)

Item 3.02 8-K / disclosure of the warrant reset strike and exercises

S-1 or registered direct after Oct 27

Reg SHO close-out ~Oct 13–14; FINRA SI ~Oct 8–9

Q3 10-Q (Nov 16): O/S, 9/30 cash, equity

BASIS+%$4.28 close 2026-09-30

LIVE STRUCTURE

08:30 ET GlobeNewswire Brazil/South America exclusive (Inovanexa; binding order 10 devices, price undisclosed, no 8-K) drove pre-market to +66% by 09:18 and +105% by 09:29 (indication only) on 15.7–19.7M sh vs 829,400 O/S; Nasdaq Panel requires equity ≥$2.5M by 2027-01-04 (6/30 $1.52M); cash ~1.4 months; shelf room $0.17–0.51M, ATM frozen, $15M ELOC not armed; unfiled Maxim-led registered offering referenced in the Streeterville note

NEXT WATCH

Public Maxim S-1 or a 424B5 under S-3 333-286711

EFFECT on resale S-1 333-298744 (deadline Oct 18)

8-K on the Inovanexa agreement (~Oct 7)

Panel confirmation of bid-price compliance

Q3 10-Q (~Nov 16): 9/30 cash and equity

BASIS+%$1.23 close 2026-09-28

LIVE STRUCTURE

No-news +305% on 291M sh on the first session after the $50M ELOC resale F-1 (156.8M sh) went effective (2026-09-25 16:15 ET); going concern with ~$0.9M cash / ~3 months at Aug 18 and ~$2.7M due Oct 9; holders own 17.70M free Class A; no lock-up expired (6-month lock-up ended Mar 2026)

NEXT WATCH

Any 424B3 / 6-K disclosing ELOC sales or commitment shares

Sep 30 2026 Class B transfer restriction lapses

Oct 9 2026 note maturities (~$2.72M)

NYSE American plan acceptance / rejection

Jul 1 2027 $0.25 minimum-price rule

BASIS+%$0.61 close 2026-09-28

LIVE STRUCTURE

$71M contract PR (07:00 ET) into a −$248.2M equity deficit and first NYSE American 1003(a) notice; issuer can print only ~$3.66M (baby shelf); holders legally can sell ~99% but insiders (73.5%) haven't sold since 2023

NEXT WATCH

Sep 30 2026 surety preferred closing + Liberty $5M payment

Oct 23 2026 compliance plan submission

~Nov 16 2026 Q3 10-Q (Liberty gain, cash)

~Apr 8 2027 S-3 shelf expiry

Jul 1 2027 $0.25 minimum-price rule

BASIS+%$2.56 close 2026-09-21

LIVE STRUCTURE

Animal Rule PR aspiration into ~655k O/S; near-term sellable = Armistice ~592k prefunded (EFFECT); milestones ~2.96M gated

NEXT WATCH

ATM/ELOC dark end ~Dec 23 2026

PA warrant first exercise ~Dec 29 2026

Clinical milestones for Series A/B/C

Panel monitor end Mar 31 2027

BASIS+%EFFECT F-3 $200M overnight; basis $0.2997 on 27.0M sh (POST 26.3M); O/S 25.4M Class A after zero-ex expansion

LIVE STRUCTURE

O/S 25.4M Class A · mcap $7.62M · F-3 EFFECT · S-8 5.09M · Class B control · bid broken 6d · Banker F · China SUBSTANTIAL

NEXT WATCH

F-3 take-down / 424

S-8 grants

bid deficiency notice

further RS

BASIS+%No EDGAR in 96h; PM partial ~5.18M sh / +77% to $8.12; basis $4.58 on ~1.57M post 1-for-12 O/S

LIVE STRUCTURE

O/S ~1.565M ordinary · mcap $7.17M · Rainforest 54% · UW wts ~10.6k @ $60 OTM≠float · no ATM · bid cured Jul 10 · GC · Banker D

NEXT WATCH

Any F-1/PP after 2025 lock-up waiver

Class-action procedural updates (Aug 6-K suit)

Cash/GC / related-party support disclosures

Same-ticker fade vs hold after no-news megavolume

Nasdaq equity buffer / MVLS if equity slips

BASIS+%Closed ClearLine+GPOX sale for 25M GPOX Series D (~$27.5M) + Emerald put; AH 75M of 77.9M sh; basis $0.1645

LIVE STRUCTURE

O/S 52.9M cover · mcap $8.70M · Titan ATM · converts ~$13.3M · bid Sep 21 · MVLS Sep 14 · equity cure CLAIMED · GC · cash ~$2M

NEXT WATCH

Sep 14, 2026 MVLS $35M deadline

Sep 21, 2026 bid-price deadline / 2nd-period notice

Nasdaq Staff response to equity-cure claim

Reverse-split proposal / proxy

ATM prints / Belleau conversions

BASIS+%Repaid ~$5.16M OID converts ahead of Sep 11; basis $2.44 on 12.7M sh (-27.4%, ~104x median) after EFFECT Sep 8 on 1.84M resale shares. Cash thin; equity monitor to Sep 30 10-Q; issuer ~$0 printable.

LIVE STRUCTURE

O/S 1.03M · resale 1.84M EFFECT · Armistice PF 597k near-common · Series A 1.06M @ $5.02 OTM≠sellable · cash thin post-repay · equity monitor to Sep 30 · SETUP: inducement-style cash pull · AFTER-CUTOFF Sep 11: 572k exercised → ~$2.87M; new 858k @ $5.02 unregistered (not free float)

NEXT WATCH

Sept 30 / Q3 10-Q Nasdaq equity evidence (≥$2.5M)

Inducement close ~Sep 14 / resale S-3 for NEW warrants EFFECT (not free float until then)

Armistice PF exercises into strength

Any tape through $5.02 Series A

Going-concern language at next audit

BASIS+%Four.meme BNC4 4Stock launch (company silent); basis $5.25 on 70.0M sh (+50.4%, 367× median)

LIVE STRUCTURE

O/S 41.26M · ATM Cantor ~$37M residual VERIFY · 49.5M stapled @ $15.15 OTM · BNB 515k / $317M · cash $3.06M

NEXT WATCH

Four.meme mint continuum / any company comment

ATM prints into strength

Permanent CEO appointment

10X Capital litigation

BNB treasury mark update

BASIS+%Overnight PROIBS US distribution 6-K; PM ~22.3M sh / $36M (+61% indication); basis $1.11 on 3.8k sh

LIVE STRUCTURE

O/S 8.07M ADS (322.8M ord @40:1) · F-3 ATM HCW I.B.5 residual ~$0.08M · free float ~95% · cash A$9.0M

NEXT WATCH

Audited FY26 by ~2026-09-30

I.B.5 T12 roll-off from ~2026-10-20

IMM-529 partnering / PROIBS US launch

BASIS+%No new wire on Sep 3 −42.61%; SEC LR-26607 + dual Nasdaq clock (10-K plan 23 Oct; bid $1 by 1 Feb 2027)

LIVE STRUCTURE

O/S 7.85M · S-3 $50M not EFFECT · warrants 1.75M @ $0.50 PP unregistered (not free float) · flippers ~1.12M

NEXT WATCH

10-K plan due 2026-10-23 (auditor vacant)

Bid $1.00 cure by 2027-02-01

BASIS+%Nasdaq 5550(a)(2) Staff Determination 2026-07-30, no 180-day Staff cure; Armistice resale S-3 not EFFECT

LIVE STRUCTURE

O/S 592,327 · baby-shelf ON · usable ATM/S-3 ~$0 · Armistice 1.71M resale S-3 not EFFECT

NEXT WATCH

10-day bid evidence 2026-09-04 (after cutoff)

Armistice S-3 EFFECT covenant ~2026-09-26 / 10-26

BASIS+%$150M TD Cowen ATM in $400M I.B.6-uncapped shelf vs equity −$9.1M

LIVE STRUCTURE

$150M ATM armed · $0 tapped · nested in $400M shelf 333-290113

NEXT WATCH

10-Q ~2026-09-09

Interest Share election through 2026-11-14 (facility, not unlock)

BASIS+%Nasdaq $1 bid deficient since 29 Jun 2026, cure 28 Dec 2026

LIVE STRUCTURE

Zero warrants / converts / ATM / shelf · unlocked paper, not new issuance

NEXT WATCH

1.41M unlock 17 Sep 2026

10 closes ≥$1 by 28 Dec 2026